Cargando…
Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation
BACKGROUND: Cystic fibrosis lung disease is characterized by chronic bacterial infections in the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest with increased respiratory symptoms that require intensification of therapy with enhanced airway clearance and int...
Autores principales: | Muhlebach, Marianne S., Sha, Wei, MacIntosh, Beth, Kelley, Thomas J., Muenzer, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424819/ https://www.ncbi.nlm.nih.gov/pubmed/32812947 http://dx.doi.org/10.1016/j.metop.2019.100010 |
Ejemplares similares
-
Lessons learned from metabolomics in cystic fibrosis
por: Muhlebach, Marianne S., et al.
Publicado: (2015) -
Metabonomics: Mining for Metabolites in Biofluids
Publicado: (2002) -
Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013) -
1078. Expectations and Attitudes Toward Antimicrobial Stewardship Among Cystic Fibrosis Care Providers
por: Bullington, Wendy, et al.
Publicado: (2019) -
Highlights from the 2016 North American Cystic Fibrosis Conference
por: Zemanick, Edith T., et al.
Publicado: (2017)